WKN: | 897914 |
ISIN: | US23918K1088 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Medizintechnik |
Weshalb die DaVita-Aktie
ein B-Rating hat,
erfahren Sie im Performance-Check
vom 01. September 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2024 | 93,94 | 146,80 | 56,27% |
2 | 2019 | 43,40 | 66,43 | 53,06% |
3 | 2005 | 14,50 | 21,30 | 46,90% |
4 | 2004 | 10,00 | 14,50 | 45,00% |
5 | 2012 | 29,05 | 41,27 | 42,07% |
6 | 2020 | 66,43 | 94,18 | 41,77% |
7 | 2014 | 46,20 | 62,29 | 34,83% |
8 | 2023 | 70,40 | 93,94 | 33,44% |
9 | 2003 | 7,67 | 10,00 | 30,38% |
10 | 2010 | 20,61 | 25,83 | 25,33% |
11 | 2009 | 17,07 | 20,61 | 20,74% |
12 | 2011 | 25,83 | 29,05 | 12,47% |
13 | 2013 | 41,27 | 46,20 | 11,95% |
14 | 2021 | 94,18 | 99,64 | 5,80% |
15 | 2015 | 62,29 | 64,25 | 3,15% |
16 | 2006 | 21,30 | 21,36 | 0,28% |
17 | 2017 | 60,92 | 60,17 | -1,23% |
18 | 2016 | 64,25 | 60,92 | -5,18% |
19 | 2008 | 19,01 | 17,07 | -10,21% |
20 | 2007 | 21,36 | 19,01 | -11,00% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2022 | 99,64 | 70,40 | -29,35% |
2 | 2018 | 60,17 | 43,40 | -27,87% |
3 | 2025 | 146,80 | 115,85 | -21,08% |
4 | 2002 | 9,00 | 7,67 | -14,78% |
5 | 2007 | 21,36 | 19,01 | -11,00% |
6 | 2008 | 19,01 | 17,07 | -10,21% |
7 | 2016 | 64,25 | 60,92 | -5,18% |
8 | 2017 | 60,92 | 60,17 | -1,23% |
9 | 2006 | 21,30 | 21,36 | 0,28% |
10 | 2015 | 62,29 | 64,25 | 3,15% |
11 | 2021 | 94,18 | 99,64 | 5,80% |
12 | 2013 | 41,27 | 46,20 | 11,95% |
13 | 2011 | 25,83 | 29,05 | 12,47% |
14 | 2009 | 17,07 | 20,61 | 20,74% |
15 | 2010 | 20,61 | 25,83 | 25,33% |
16 | 2003 | 7,67 | 10,00 | 30,38% |
17 | 2023 | 70,40 | 93,94 | 33,44% |
18 | 2014 | 46,20 | 62,29 | 34,83% |
19 | 2020 | 66,43 | 94,18 | 41,77% |
20 | 2012 | 29,05 | 41,27 | 42,07% |